Abu Dhabi PPP Initiative

The New Standard of Global Pharma.

Building a smart, sustainable, and fully integrated pharmaceutical ecosystem in the heart of the UAE. A strategic partnership between sovereign enterprise and global innovation.

50 km²
Industrial Footprint
$1–15B
Phased Investment
5
Manufacturing Divisions
Net-0
Sustainability Target

Integrated Ecosystem

Our infrastructure supports the entire pharmaceutical value chain — from traditional therapeutics to advanced molecular research and sustainable manufacturing.

All Divisions →
01.

Generic Formulations

Mass-scale production of essential medicines with a focus on regional health security and cost-optimization.

Generic Formulations
02.

Ayurvedic & Natural

Integrating ancient wisdom with modern clinical standards to deliver proven herbal and natural therapeutic solutions.

Ayurvedic & Natural
03.

Advanced R&D

Pioneering molecular biology and biotechnology breakthroughs through strategic sovereign-backed innovation hubs.

Advanced R&D
Vision in Motion

A Glimpse of the Future Ecosystem.

From the Abu Dhabi skyline to the manufacturing floor — a preview of the ADPIC industrial city as it takes shape.

01.Corporate Identity↓ Transcript
02.Manufacturing↓ Transcript
03.Industrial City I↓ Transcript
04.Industrial City II↓ Transcript
05.Industrial City III↓ Transcript
06.Investment Opportunity↓ Transcript
07.From Abu Dhabi↓ Transcript
08.Abu Dhabi Skyline↓ Transcript
09.Manufacturing Hub I↓ Transcript
10.Manufacturing Hub II↓ Transcript
11.Manufacturing Hub III↓ Transcript

Click any tile to play with sound. Captions and transcripts available for every clip.

2026–2035 Roadmap

The Path to Regional
Leadership.

Strategic phasing designed to scale production while integrating carbon-neutral infrastructure and smart-city logistics.

View Full Roadmap →
Yr 1–3

Phase 1 — Foundation

Generic medicine factory, packaging, QC lab, warehousing, and training center commissioning.

Yr 3–6

Phase 2 — Natural Expansion

Ayurvedic, homeopathic, and natural wellness zones with expanded R&D and cold-chain logistics.

Yr 6–10

Phase 3 — Global Hub

Sterile injectables, biotech park, pharma university, and a full export hub serving 45+ markets.